Other News
Milestone for women’s HIV prevention: European Medicines Agency gives dapivirine ring the OK
UW School of Public Health | Aug. 4, 2020
/content/dam/www/people-profile-photos/b/elizabeth-brown/elizabeth-brown-d.jpg
Brown
Elizabeth Brown, ScD
- Professor, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
- Professor, Biostatistics Program, Public Health Sciences Division, Fred Hutch
- Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
- Research Professor, Biostatistics, University of Washington
- Graduate Faculty, Biostatistics, University of Washington
Background
Dr. Elizabeth Brown is a biostatistician engaged in the design and analysis of infectious disease clinical trials, including COVID-19, HIV/AIDS and HPV. She is the principal investigator for the Statistical and Data Management Center of the Microbicide Trials Network, which carries out clinical research on interventions designed to prevent the sexual transmission of HIV. Dr. Brown is also the Director of the Statistical and Data Sciences Unit for the Infectious Diseases Clinical Consortium, a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases. Dr. Brown also leads statistical methods research with a focus on Bayesian survival on longitudinal models for infectious disease transmission and prevention.
Principal Investigator, Statistical and Data Management Center
Microbicide Trials Network
Director, Statistical and Data Sciences Unit
Infectious Diseases Clinical Research Consortium
Education
Harvard University, 2002, ScD (Biostatistics)
University of Colorado, 1998, MS (Biometrics)
University of Virginia, 1994, BS (Mechanical Engineering)
Research Interests
Design and analysis of trials for HIV prevention
Joint models for longitudinal and survival data
Statistical methods in HIV/AIDS and cardiovascular research
Current Projects
Microbicide Trials Network-Leadership of the Statistical and Data Management Center
Infectious Diseases Clinical Research Consortium -Leadership Group
Treatment for SARS-CoV-2 in Adult Outpatients
Post-exposure prophylaxis for SARS-CoV-2
KENya Single-dose HPV-vaccine Efficacy (KEN SHE) Study
HIV Prevention Trials Network